News and Trends 20 Jan 2023
Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy
Brenus Pharma and InSphero AG have received a €1.5 million grant for the collaborative project "STC-1010: A First-in-Class Allogeneic Cell…